RecruitingPhase 3NCT07404865
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Sponsor: Vor Biopharma
Kansas City, MO · +46 more sites
5 recruiting rheumatoid arthritis studies with a site in Kansas City, MO.
All trials in Kansas City, MO · All Rheumatoid Arthritis trials
Sponsor: Vor Biopharma
Kansas City, MO · +46 more sites
Sponsor: AstraZeneca
Kansas City, MO · St Louis, MO · +27 more sites
Sponsor: National Cancer Institute (NCI)
City of Saint Peters, MO · Creve Coeur, MO · Kansas City, MO · +48 more sites
Sponsor: Duke University
Kansas City, MO · St Louis, MO · +72 more sites
Sponsor: Amgen
Kansas City, MO · +30 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.